Should you buy ZYDUSLIFE.BO stock?
Last updated:
Based on market data through , StockInvest.us rates Zydus Lifesciences Limited (ZYDUSLIFE.BO) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.
- Hold signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Up 11.71%
- Beat earnings estimates in all of the last 4 quarters
- Healthy interest coverage ratio of 17.7x
- Strong operating margin of 28.6%
Strong day for Zydus Lifesciences Limited stock price on Tuesday rising 5.29% to ₹1,180.00
(Market data through Aug 11, 2026)
The Zydus Lifesciences Limited stock price gained 5.29% on the last trading day (Tuesday, 11th Aug 2026), rising from ₹1,120.70 to ₹1,180.00. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 8.04% from a day low at ₹1,115.35 to a day high of ₹1,205.00. The price has risen in 6 of the last 10 days and is up by 7.31% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 662 thousand more shares were traded than the day before. In total, 715 thousand shares were bought and sold for approximately ₹843.16 million.
The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.71% during the next 3 months and, with a 90% probability hold a price between ₹1,251.12 and ₹1,348.05 at the end of this 3-month period.
ZYDUSLIFE.BO Signals & Forecast
The Zydus Lifesciences Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at ₹1,123.99 and ₹1,127.26. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 28, 2026, and so far it has risen 7.31%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Zydus Lifesciences Limited stock
Zydus Lifesciences Limited finds support from accumulated volume at ₹1,152.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved ₹89.65 between high and low, or 8.04%. For the last week the stock has had daily average volatility of 3.22%.
Our recommended stop-loss: ₹1,130.00 (-4.24%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (ZYDUSLIFE.BO) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Zydus Lifesciences Limited to open at ₹1,166.78, and during the day (based on 14 day Average True Range), to move between ₹1,165.37 and ₹1,194.63, which gives a possible trading interval of +/-₹29.26 (+/-2.51%) up or down from last closing price. If Zydus Lifesciences Limited takes out the full calculated possible swing range there will be an estimated 2.51% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ ₹1,152.90, some ₹27.10 (2.30%) from the current price of ₹1,180.00, our system finds the risk reward attractive.
Is Zydus Lifesciences Limited stock A Buy?
Zydus Lifesciences Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - ₹1,166.78 ( 1.12%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ZYDUSLIFE.BO Performance
Trading levels for ZYDUSLIFE.BO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1,256.43 | 6.48% |
| R2 | 1,222.19 | 3.58% |
| R1 | 1,201.03 | 1.78% |
| Price | 1,180.00 | |
| S1 | 1,132.54 | -4.02% |
| S2 | 1,111.38 | -5.82% |
| S3 | 1,077.13 | -8.72% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 1,180.00 | |
| S1 | 1,152.90 | -2.30% |
| S2 | 1,149.00 | -2.63% |
| S3 | 1,018.95 | -13.65% |
ZYDUSLIFE Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 25, 2025 | Jul 25, 2025 | Sep 11, 2025 | ₹11.00 | 1.22% |
| 2 | Jul 26, 2024 | Jul 26, 2024 | Sep 08, 2024 | ₹3.00 | 0.273% |
| 3 | Jul 28, 2023 | Jul 28, 2023 | Sep 10, 2023 | ₹6.00 | 0.96% |
| 4 | Jul 28, 2022 | Jul 28, 2022 | Aug 16, 2022 | ₹2.50 | 0.627% |
| 5 | Jul 28, 2021 | Jul 28, 2021 | Sep 10, 2021 | ₹3.50 | 0.627% |
FAQ
Click here for our free guide on how to buy Zydus Lifesciences Limited Stock.
Buy ZYDUSLIFE